Delivery Order SPE2DR25D3501-SPE2DR26FM2VR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (30-count) on January 6, 2026, with a contract ceiling value of $5,823.04 and an ultimate completion date of January 7, 2026. This is a firm fixed-price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and running through December 2026. The work will be...
- The Defense Logistics Agency awarded a delivery order to AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., for Isotretinoin 30 mg capsules (30-count) on January 16, 2026, with a ceiling value of $2,193.34 and an ultimate completion date of January 20, 2026. This is a firm fixed-price, non-set-aside delivery order with performance in Conshohocken, Pennsylvania. The award falls under AmerSourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,257.99 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (10-count units) on January 21, 2026, with an ultimate completion date of January 22, 2026. The contract utilizes a firm fixed-price structure with no set-aside designation, indicating full and open competition. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $5,713.26 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on December 4, 2025, with completion scheduled for December 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Isotretinoin is a potent retinoid medication primarily used for severe acne...
- The Defense Logistics Agency awarded a delivery order valued at $6,962.71 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on January 9, 2026, with an ultimate completion date of January 12, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Isotretinoin 40 mg capsules in quantities of 30 units, with a ceiling value of $1,390.74 and an ultimate completion date of December 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Isotretinoin is a potent retinoid medication...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) under a firm fixed-price contract valued at $1,567.38. The contract was awarded on January 2, 2026, with an ultimate completion date of January 5, 2026, and represents a non-set-aside competitive award. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,868.79 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA. The work will be performed at the contractor's corporate...
- The Defense Logistics Agency awarded a $1,123.46 delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Isotretinoin 30 mg capsules (30-count units), with completion scheduled for January 5, 2026. This competitive award, utilizing firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of 30 units. This is a firm fixed-price delivery order valued at $8,552.77, with an ultimate completion date of October 21, 2025. The contract is a non-set-aside award, meaning it was competitively awarded without preference restrictions. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location,...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FM2VRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerSourceBergen Drug Corp on January 21, 2026, for the supply of Isotretinoin 30 mg capsules (30-count units) with a contract value of $5,825.91 and an ultimate completion date of January 22, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerSourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. Isotretinoin is a prescription medication primarily used for severe acne treatment and represents part of the comprehensive pharmaceutical portfolio that Cencora and its subsidiary AmerSourceBergen provide through their federal contracts. As a major pharmaceutical distributor specializing in federal medical procurement, the company supplies an extensive range of medications, medical devices, and healthcare commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The DLA's procurement through this vehicle ensures availability of critical pharmaceutical products across the defense healthcare supply chain to support military personnel and beneficiaries worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 1/20/26 |